 |
|
Antioxidants do not prevent degenerative eye disease
October 09, 2007Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis BMJ Online First
A diet rich in antioxidant vitamins and minerals does not seem to prevent the degenerative eye disease known as age related macular degeneration, finds a study published on bmj.com today.
Age related macular degeneration is the leading cause of visual loss in older people. It is caused by the progressive break down of light sensitive cells in the macula, located in the centre of the retina at the back of the eye. Sufferers do not go blind, but find it virtually impossible to read, drive, or do tasks requiring fine, sharp, central vision.
Risk increases with age and smokers are thought to be more susceptible.
Antioxidants (such as vitamin C, vitamin E, various types of carotenoids, and zinc) are thought to reduce oxidative damage to the retina. But the evidence to support the role of dietary antioxidants in preventing macular degeneration remains unclear.
So researchers at the Centre for Eye Research Australia, the University of Melbourne analysed the evidence to examine the role of dietary antioxidants or dietary supplements in the primary prevention of age related macular degeneration.
They identified 11 studies (seven prospective studies and three randomised controlled trials) involving 149,203 people. A range of common dietary antioxidants were investigated and all the studies were carried out amongst well nourished Western populations with an average follow-up period of nine years.
Importantly, all the studies adjusted for age and smoking in their analyses.
The antioxidants investigated differed across studies, but when results were pooled they showed that vitamin A, vitamin C, vitamin E, zinc, lutein, zeaxanthin, α- carotene, β-carotene, β-cryptoxanthin and lycopene have little or no effect in the primary prevention of early age-related macular degeneration.
None of the three trials found antioxidant supplements to be protective in the primary prevention of early age related macular degeneration.
Despite some study limitations, the authors conclude that there is insufficient evidence to support the role of dietary antioxidants, including the use of dietary antioxidant supplements, for the primary prevention of early age-related macular degeneration.
Currently, cigarette smoking remains the only widely accepted modifiable risk factor for the primary prevention of early age-related macular degeneration, and patients seeking advice on this condition should be encouraged to quit, they add.
An accompanying editorial by Jennifer Evans at the International Centre for Eye Health supports these findings and says that reducing the prevalence of smoking is probably the most effective method of reducing the population burden of this common cause of visual loss in older people.
BMJ-British Medical Journal
Risk increases with age and smokers are thought to be more susceptible.
Antioxidants (such as vitamin C, vitamin E, various types of carotenoids, and zinc) are thought to reduce oxidative damage to the retina. But the evidence to support the role of dietary antioxidants in preventing macular degeneration remains unclear.
So researchers at the Centre for Eye Research Australia, the University of Melbourne analysed the evidence to examine the role of dietary antioxidants or dietary supplements in the primary prevention of age related macular degeneration.
They identified 11 studies (seven prospective studies and three randomised controlled trials) involving 149,203 people. A range of common dietary antioxidants were investigated and all the studies were carried out amongst well nourished Western populations with an average follow-up period of nine years.
Importantly, all the studies adjusted for age and smoking in their analyses.
The antioxidants investigated differed across studies, but when results were pooled they showed that vitamin A, vitamin C, vitamin E, zinc, lutein, zeaxanthin, α- carotene, β-carotene, β-cryptoxanthin and lycopene have little or no effect in the primary prevention of early age-related macular degeneration.
None of the three trials found antioxidant supplements to be protective in the primary prevention of early age related macular degeneration.
Despite some study limitations, the authors conclude that there is insufficient evidence to support the role of dietary antioxidants, including the use of dietary antioxidant supplements, for the primary prevention of early age-related macular degeneration.
Currently, cigarette smoking remains the only widely accepted modifiable risk factor for the primary prevention of early age-related macular degeneration, and patients seeking advice on this condition should be encouraged to quit, they add.
An accompanying editorial by Jennifer Evans at the International Centre for Eye Health supports these findings and says that reducing the prevalence of smoking is probably the most effective method of reducing the population burden of this common cause of visual loss in older people.
BMJ-British Medical Journal
Macular Degeneration Current Events and Macular Degeneration News RSSSunlight exposure plus low antioxidant levels may place older adults at risk for eye disease
A European study suggests that the combination of low plasma levels of antioxidants and blue light exposure from the sun is associated with certain forms of the eye disease age-related macular degeneration (AMD), according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Case Western Reserve University research finds drug candidate slows age-related macular degeneration
Research results from the Case Western Reserve University School of Medicine show that the progression of age-related macular degeneration (AMD) is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab.
Receptor could halt blinding diseases, stop tumor growth, preserve neurons after trauma
An international team of researchers has discovered what promises to be the on-off switch behind several major diseases.
Discovery of natural compounds that could slow blood vessel growth
Using computer models and live cell experiments, biomedical engineers at the Johns Hopkins University School of Medicine have discovered more than 100 human protein fragments that can slow or stop the growth of cells that make up new blood vessels.
Iron-moving malfunction may underlie neurodegenerative diseases, aging
A glitch in the ability to move iron around in cells may underlie a disease known as Type IV mucolipidosis (ML4) and the suite of symptoms---mental retardation, poor vision and diminished motor abilities---that accompany it, new research at the University of Michigan shows.
Eat oily fish at least once a week to protect your eyesight in old age
Eating oily fish once a week may reduce age-related macular degeneration (AMD) which is the major cause of blindness and poor vision in adults in western countries and the third cause of global blindness, according to a study published today in the American Journal of Clinical Nutrition.
Hyperactive immune resistance brings blindness in old age
Age-dependent macular degeneration (AMD) is the commonest cause of blindness in the western industrialised nations. Hereditary changes in the regulation of the immune system influence the risk of contracting AMD.
Telescope embedded in glasses lens promises to make driving easier for visually impaired
Glasses embedded with a telescope promise to make it easier for people with impaired vision to drive and do other activities requiring sharper distance vision.
Retina transplants show promise in patients with retinal degeneration
Preliminary research shows encouraging results with transplantation of retinal cells in patients with blindness caused by retinitis pigmentosa (RP) and age-related macular degeneration (AMD).
New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
More Macular Degeneration Current Events and Macular Degeneration News Articles
 | Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight by Lylas G. Mogk, Marja Mogk The acclaimed book on macular degeneration—now completely revised and updated with cutting edge research and the latest developments in the field.More than fifteen million Americans have age-related macular degeneration (AMD), and the disease will strike 200,000 more people this year. It is the most prevalent cause of vision loss in the western world. Dr. Lylas Mogk, the founding director of... |
 | Macular Degeneration: The Latest Scientific Discoveries and Treatments for Preserving Your Sight by Robert D'Amato M.D. Ph.D., Joan Snyder, M.D., Ph.D. Robert D'Amato Dr. Robert D'Amato, MD, PhD of Harvard Medical School,and recent winner of the Lew Wasserman award for his pioneering eye research, has teamed up with ARMD sufferer and writer Joan Snyder, to produce Macular Degeneration: The Latest Scientific Discoveries and Treatments for Preserving Your Sight. Endorsed by the Macular Degeneration Foundation, this easy-to-read large type edition is the only... |
 | Macular Degeneration: A Complete Guide for Patients and Their Families by Michael A. Samuel For people who start losing their vision to macular degeneration, the prospect of impending blindness is frightening and terribly depressing. They often get contradictory advice about surgery, medical treatments, natural supplements, and lifestyle changes that might arrest or reverse the condition, and these conflicting recommendations only compound their anxiety.Finally, in Macular Degeneration:... |
 | Protect Your Sight: How to Save Your Vision in the Epidemic of Age-Related Macular Degeneration by James C. Folk, Mark E. Wilkinson James Folk, MD and Mark Wilkinson, OD are professors at the University of Iowa. They are experts in the field of macular degeneration, and they are not being paid by anyone to recommend anything. They treat patients with age-related macular degeneration almost every day, perform research that explores the causes of AMD, attend scientific meetings, participate in treatment trials, and promise to... |
| Living Well with Macular Degeneration: Practical Tips and Essential Information by Bruce P. Rosenthal, Kate Kelly Written by one of the nation's leading experts on the subject, this new guide offers the most up-to-date information, advice and support to the growing number of people with age-related macular degeneration. Based on the latest on-going research, it includes:• A clear explanation of the symptoms and causes of AMD• Advice on seeking medical help and "low vision" centers• Latest research on... | |
 | Overcoming Macular Degeneration : A Guide to Seeing Beyond the Clouds Each year, more than 400,000 Americans are diagnosed with macular degeneration, an age-related, progressive eye disease that immediately raises a fear of total blindness. The good news is: YOU ARE NOT GOING BLIND. However, you are dealing with a disease that causes serious visual impairment--an inconvenience the author, Dr. Yale Solomon, has become personally familiar with since he was diagnosed... |
| Macular Degeneration: A Comprehensive Guide to Treatment, Breakthroughs and Coping Strategies by Robert D'Amato, Joan Snyder Dr. Robert D'Amato, MD, PhD of Harvard Medical School,and recent winner of the Lew Wasserman award for his pioneering eye research, has teamed up with ARMD sufferer and writer Joan Snyder, to produce Macular Degeneration: The Latest Scientific Discoveries and Treatments for Preserving Your Sight. Endorsed by the Macular Degeneration Foundation, this easy-to-read large type edition is the only... | |
 | The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed by Daniel L. Roberts Age-related macular degeneration (AMD) is a progressive disease of the retina that develops when the light-sensing cells in the central area of vision (the macula) stop working and eventually die. Thought to be caused by a combination of genetic and environmental factors, the disease is the leading cause of blindness in people over 50. In 1995, Dan Roberts retired from teaching to help others who... |
| The Macular Degeneration Handbook: Natural Ways to Prevent & Reverse It by Chet Cunningham | |
 | Macular Degeneration Handbook by Chet Cunningham Those who suffer from Macular Degeneration or other degenerative eye diseases including Cataracts, Lacoma, Retinitis Pigmentosa and eye diseases associated with diabetes can benefit from this book. Readers learn symptoms, causes, treatments and prevention strategies using all-natural and alternative methods. The book shows how nutrition, dietary supplements, exercises and other methods can bring... |
| © 2008 BrightSurf.com |